Jill Wahleithner

Jill Wahleithner is a Senior Research Analyst at Wasatch Global Investors, based in Seattle, WA. She joined the firm in 2013 and applies her deep scientific expertise to researching and analyzing investment opportunities, with a particular focus on the biotechnology sector. Her responsibilities include scientific and financial due diligence, stock selection, and helping Wasatch navigate growth opportunities and risk within the volatile biotech industry, as well as contributing to strategies that leverage biotech and pharmaceutical holdings.

Wahleithner’s investment research centers on biotechnology and pharmaceutical companies, reflecting her academic and professional background in biological sciences. Prior to joining Wasatch, she was the founder of Type III Research, a biotech consulting firm, and worked for a decade as a research scientist with Novo Nordisk and in academia as a post-doctoral researcher at UC Davis.

She holds a PhD in Biology from the University of Utah, which underpins her detailed understanding of scientific advancements and their potential impact on capital markets. Her contributions include advancing Wasatch’s performance in biotech stock selection and helping the firm maintain a disciplined, risk-mitigated approach to investing in innovative, high-growth sectors.